Q1 Earnings Forecast for SNDX Issued By HC Wainwright
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Syndax Pharmaceuticals in a note issued to investors on Tuesday, March 4th. HC Wainwright analyst E. White expects that the company will post earnings of ($1.00) per share for the […]
